Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005

Vaccine

Volumn 25, Issue 7, 2007, Pages 1275-1280

  Phongsamart, Wanatpreeya ^a   Srifeungfung, Somporn ^a   Dejsirilert, Surang ^a   Chatsuwan, Tanittha ^a   Nunthapisud, Pongpun ^a   Treerauthaweeraphong, Vipa ^a   Rungnobhakhun, Pimpha ^a   Chokephaibulkit, Kulkanya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antimicrobial susceptibility; Pneumococcal conjugate vaccine; Serotypes; Streptococcus pneumoniae; Thai children

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILDHOOD DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; THAILAND; VACCINATION;

CEFOTAXIME; CEPHALOSPORINS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; THAILAND;

EID: 33845883019     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.001     Document Type: Article

References (52)

1. American Academy of Pediatrics Committee on Infectious Diseases. Policy statement: recommendation for the prevention of pneumococcal infections, including the use of pneumococcal conjugated vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis. Pediatrics 106 2 (2000) 362-366
2. Centers for Disease Control Prevention. Preventing pneumococcal disease among infants and young children. MMWR 49 (2000) 1-35
3. Alpern E.R., Alessandrini E.A., McGowan K.L., Bell L.M., and Shaw K.N. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics 108 2 (2001) e23
4. Shapiro E.D., and Autrian R. Serotypes responsible for invasive Streptococcus pneumoniae infection among children in Connecticut. J Infect Dis 169 (1994) 212-214
5. Butler J.C., Breiman R.F., Lipman H.B., Hofmann J., and Facklam R.R. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implication for development of a conjugate vaccine. J Infect Dis 171 (1995) 885-889
6. Hausdroff W.P., Bryant J., Paradiso P.R., and Siber G. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30 (2000) 100-121
7. Hausdroff W.P., Siber G., and Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 357 (2001) 950-952
8. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
9. Shinefield H., and Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 19 (2000) 394-397
10. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
11. Nachman S., Kim S., King J., Abrams E.J., Margolis D., Petru A., et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 112 (2003) 66-73
12. Whitney C.G., Farley M.M., Hardler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
13. Black S., Shinefeld H., Baxter R., Austrian R., Bracken L., Hansen J., et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern Kaiser Permanente. Pediatr Infect Dis J 23 6 (2004) 485-489
14. Kaplan S.L., Manson E.O., Wald E.R., Schutze G.E., Bradley J.S., Tan T.Q., et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113 (2004) 443-449
15. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Mitchel E., et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39 (2004) 641-648
16. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., and Kleein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. The Massachusetts Department of Public Health Epidemiologists. Pediatr Infect Dis J 24 (2005) 17-23
17. Haddy R.I., Perry K., Chacko C.E., Helton W.B., Bowling M.G., Looney S.W., et al. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 24 (2005) 320-323
18. Reinert R.R., Reinert S., van der Linden M., Cil M.Y., Al-Lahham A., and Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 49 7 (2005) 2903-2913
19. Farrell D.J., Jenkins S.G., and Reinert R.R. Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators. J Med Microbiol 53 (2004) 1109-1117
20. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48 6 (2004) 2101-2107
21. Castanheira M., Gales A.C., Mendes R.E., Jones R.N., and Sader H.S. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program. Clin Microbiol Infect 10 7 (2004) 645-651
22. Huebner R.E., Wasas A.D., and Klugman K.P. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int J Infect Dis 4 4 (2000) 214-218
23. Joloba M.L., Windau A., Bajaksouzian S., Appelbaum P.C., Hausdorff W.P., and Jacobs M.R. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis 33 9 (2001) 1489-1494
24. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 14 (2003) 1341-1348
25. Puumalainen T., Zeta-Capeding R., Kayhty H., Lucero M.G., Auranen K., Leroy O., et al. Antibody response to an eleven valent diptheria- and tetanus- conjugated pneumococcal vaccine in Filipino infants. Pediatr Infect Dis 21 (2002) 309-314
26. Nurkka A., Joensuu J., Henckaerts I., Peeters P., Poolman J., Kilpi T., et al. Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr Infect Dis J 23 11 (2004) 1008-1014
27. Lucero M.G., Puumalainen T., Ugpo J.M., Williams G., Kayhty H., and Nohynek H. Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial. J Infect Dis 189 11 (2004) 2077-2084
28. Hausdorff W.P. Invasive pneumococcal disease in children: geographic and temporal variations in the incidence and serotype distribution. Eur J Pediatr 161 Suppl. 2 (2002) S135-S139
29. Rorks-Ngam S., Treleaven S., and Chunsultiwat S. Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. Vaccine 22 (2004) 975-983
30. Chotpitayasunondh T. Bacterial meningitis in children: etiology and clinical features, an 11-year review of 618 cases. Southeast Asian J Trop Med Public Health 25 (1994) 107-115
31. Clinical Laboratory Standards Institute. Performance standard for antimicrbial and susceptibility testing. 15th Information Supplement (M- 100-S15) (2005), Clinical and Laboratory Standards Institute, Wayne, PA
32. Sunakorn P., Kusum M., Dejsirilert S., Saengsuk L., Sareebutara W., and Kwanpairoj P. The serotypes of Streptococcus pneumoniae isolated from patients with acute respiratory infections in Thailand. Com Dis J 22 (1996) 72-77
33. Dejsirilert S., Overweg K., Sluijter M., Saengsuk L., Gratten M., Ezaki T., et al. Nasopharyngeal carriage of penicillin-resistant of Streptococcus pneumoniae among children with acute respiratory tract infections in Thailand: a molecular epidemiological survey. J Clin Microbiol 37 (1999) 1832-1838
34. Lee N.Y., Song J.H., Kim S., Peck K.R., Ahn K.M., Lee S.I., et al. Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infect Dis 32 10 (2001) 1463-1469
35. Levine S., Dejsirilert S., Leelaowadee S., Chantra S., Feikin D.R., Dowell S.F., et al. Serotypes and antimicrobial resistance of Streptococcus pneumoniae in Thailand 2002-2004. Ped Infect Dis J 25 (2006) 176-178
36. Hsueh P.R., Uw J.J., and Hsiue T.R. Invasive Streptococcus pneumoniae infection associated with rapidly fatal outcome in Taiwan. J Formos Med Assoc 95 (1996) 364-371
37. Saha S.K., Rikitomi N., Biswas D., Watanabe K., Ruhulamin M., Ahmed K., et al. Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992-1995. J Clin Microbiol 35 (1997) 785-787
38. Rahav G., Toledano Y., Engelhard D., Simhon A., Moses A.E., Sacks T., et al. Invasive pneumococcal infections: a comparison between adults and children. Medicine 76 (1997) 295-303
39. Invasive Bacterial Infection Surveillance (IBIS) Group I. Prospective multicenter hospital surveillance of Streptococcus pneumoniae disease in India. Lancet 353 (1999) 1216-1221
40. Capeding M.R.Z., Sombrero L.T., Lucero M.G., and Saniel M.C. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children. J Infect Dis 169 (1994) 479-480
41. Mastro T.D., Ghaffor A., Nomani N.K., Ishaq Z., Anwar F., Granoff D.M., et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 337 (1991) 156-159
42. Nahm M.H., Olander J.V., and Magyalaki M. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J Infect Dis 176 (1997) 698-703
43. Yu X., Gray B., Chang S., Ward J.I., Edwards K.M., and Nahm M.H. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis 180 (1999) 1569-1576
44. Vakevainen M., Eklund C., Eskola J., and Kayhty H. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis 184 (2001) 789-793
45. Dagan R., Yagupsky P., Goldbart A., Wasas A., and Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 13 (1994) 782-786
46. Breiman R.F., Butler J.C., Tenover F.C., Elliott J.A., and Facklam R.R. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271 (1994) 1831-1835
47. Haglund L.A., Istre G.R., Pickett D.A., Weld D.F., and Fine D.P. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin-resistance and multiple antibiotic resistance. J Infect Dis 168 (1993) 1532-1536
48. Welby P.L., Keller D.S., Cromien J.L., Tebas P., and Storch G.A. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J 13 (1994) 281-287
49. Ubukata K., Chiba N., Hasegawa K., Kobayashi R., Iwata S., and Sunakawa K. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999-2002. Antimicrob Agents Chemother 48 5 (2004) 1488-1494
50. Zissis N.P., Syriopoulou V., Kafetzis D., Daikos G.L., Tsilimingaki A., Galanakis E., et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr 163 7 (2004) 364-368
51. Chokephaibulkit K., Srifuengfung S., Mingbanjerdsuk J., Tosasuk K., Vanprapar N., Chearskul S., et al. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998. Southeast Asian J Trop Med Public Health 31 (2000) 498-505
52. Pancharoen C., Chongthaleong A., Reinprayoon S., and Thisyakorn U. Invasive pneumococcal infection and drug-resistant Streptococcus pneumoniae in Thai children. J Med Assoc Thai 84 9 (2001) 1246-1250